Gene Transfer Study of ABO-102 in Patients With Middle and Advanced Phases of MPS IIIA Disease

Clinical trial NCT04088734 · TERMINATED

Trial details

NCT number: NCT04088734
Sponsor: Ultragenyx Pharmaceutical Inc
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

MPS IIIA Sanfilippo Syndrome Sanfilippo A Mucopolysaccharidosis III

Start date: 2019-09-18
Primary completion: 2022-03-10
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.